The present invention provides a compound represented by the formula (1):
wherein each symbol is as defined in the specification, or a salt thereof, a prodrug of the compound or a salt thereof, a medicament containing the compound or a salt thereof, the medicament which is a phosphodiesterase 10A inhibitor, and a medicament which is for preventing or treating schizophrenia.
[EN] RADIOLABELED COMPOUNDS AND THEIR USE AS RADIOTRACERS FOR QUANTITATIVE IMAGING OF PHOSPHODIESTERASE (PDE10A) IN MAMMALS<br/>[FR] COMPOSÉS RADIOMARQUÉS ET LEUR UTILISATION EN TANT QUE RADIOTRACEURS POUR L'IMAGERIE QUANTITATIVE DE LA PHOSPHODIESTÉRASE (PDE10A) CHEZ LES MAMMIFÈRES
申请人:TAKEDA PHARMACEUTICAL
公开号:WO2013027845A1
公开(公告)日:2013-02-28
The present invention provides radiolabeled compounds useful as radiotracers for quantitative imaging of PDE10A in mammals. The compound of the present invention is represented by the formula (I): wherein each symbols are as defined in the specification.
RADIOLABELED COMPOUNDS AND THEIR USE AS RADIOTRACERS FOR QUANTITATIVE IMAGING OF PHOSPHODIESTERASE (PDE10A) IN MAMMALS
申请人:Taniguchi Takahiko
公开号:US20140178304A1
公开(公告)日:2014-06-26
The present invention provides radiolabeled compounds useful as radiotracers for quantitative imaging of PDE10A in mammals. The compound of the present invention is represented by the formula (I): wherein each symbols are as defined in the specification.